Severe acute respiratory syndrome, a novel coronavirus first identified in Guangdong province in November 2002, spread internationally after an infected physician, Liu Jianlun, stayed a single night at Hong Kong's Metropole Hotel in February 2003 and unknowingly transmitted the virus to guests on the same floor who carried it onward to Vietnam, Singapore, and Canada within days of checking out.

The World Health Organization issued a rare global health alert on March 12, 2003, and Italian physician Carlo Urbani, who first identified SARS as a distinct novel threat while working in Hanoi, died of the disease himself weeks later — a death that gave the outbreak an early, sobering human face inside the international public-health establishment and accelerated global cooperation.

Governments experimented in real time with response tools that had no settled playbook to draw on: airport thermal-imaging screening, formal quarantine orders enforced by police in Toronto and Singapore, and daily public case-count briefings as a deliberate communication strategy to maintain public trust. The WHO's authority to name affected regions and issue travel advisories, controversially applied against Toronto to Canadian officials' considerable public frustration, expanded in ways member states had not fully anticipated when the organization was founded decades earlier.

The outbreak ultimately infected roughly 8,096 people and killed 774 worldwide by the time it was declared contained in July 2003 — figures dramatically smaller than later pandemics, yet tourism-dependent economies in Hong Kong, Singapore, and Toronto lost billions of dollars in economic activity within a matter of weeks, proof that a densely networked, mobile modern world could suffer economic contagion wildly out of proportion to a pathogen's actual death toll.

Coverage largely treated SARS as a solved crisis once case counts fell in mid-2003 and the WHO lifted its advisories. Public-health researchers who studied the response more closely flagged persistent structural gaps that went substantially unaddressed for the next seventeen years: delayed disclosure by Chinese provincial authorities during the outbreak's critical first months, and dangerously thin national stockpiles of basic protective equipment like N95 respirators.

Nearly every tool deployed against COVID-19 in 2020 had a direct SARS-era rehearsal: temperature screening at international airports, contentious contact-tracing debates, stigma directed unfairly at Asian communities in multiple countries, and political arguments over exactly when travel restrictions and business closures were economically justified relative to a still-uncertain public-health benefit.

Severe acute respiratory syndrome spread from Guangdong through Hong Kong and into multiple continents in 2002–2003. The World Health Organization issued rare travel advisories; cities such as Toronto and Singapore ran contact-tracing and quarantine regimes that later looked like dress rehearsals for COVID-19.

The template that stuck included genomic identification of a novel coronavirus, airport health screening theater, hospital infection-control upgrades, and the political discovery that an outbreak elsewhere could shutter hotels and airlines at home within days. SARS killed far fewer people than later pandemics, but it taught health ministries that transparency delays were themselves a transmission risk.

China's early information controls and later cooperation became a lasting case study in outbreak diplomacy. The International Health Regulations were revised in 2005 partly in reaction to SARS-era gaps, trying to obligate faster notification — a legal layer COVID would later strain in public view.

Hong Kong's Amoy Gardens cluster and Toronto's hospital amplifications taught aerosol and fomite lessons under brutal time pressure. WHO's travel advisories — rare and economically painful — established that a Geneva-based alert could move airline load factors within days, a power COVID later made familiar worldwide.

China's initial opacity and subsequent cooperation became the template argument for International Health Regulations reform in 2005: notification duties, verification, and the politics of naming a PHEIC. Those legal instruments were on the books when SARS-CoV-2 emerged; compliance and trust were the binding constraints.

Hospital infection-control drills and airport thermal cameras became muscle memory in East Asian cities that later reacted faster to COVID. The template was unevenly learned: places that suffered SARS invested; places that watched from afar often underinvested. Pathogen memory is local until it isn’t.

The International Health Regulations, substantially revised by WHO member states in 2005 partly in direct response to SARS's disclosure delays, created the binding legal framework nations were still formally relying on — and, by many accounts, still partially violating — when a new coronavirus emerged in Wuhan, China, in December 2019.

Century Signals note: WHO SARS chronologies; contemporaneous reporting in Hong Kong, Singapore, Toronto; IHR (2005) reform materials. Editorial judgment about what still structures the present — not a comprehensive history.